Monte L. Anderson - Concepedia

Concepedia

Author

Monte L. Anderson

Mayo Clinic in Arizona

Also Known As

M L Anderson, MONTE L. ANDERSON, Monte Anderson, Monte L Anderson, Monte L. Anderson

18

Publications

1.5K

Citations

12

H-Index

36

Concepts

All Affiliations

Mayo Clinic in Arizona Mayo Clinic Jacksonville College Mayo Clinic in Florida University of California San Diego

ML

About

Monte L. Anderson is an author at Mayo Clinic in Arizona specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1K
2	Hepatology	7	7	825
3	Gastroenterology	3	3	178
4	Health Sciences	1	1	72
5	Epidemiology	1	1	72

Monte L. Anderson

×

12

Publications

1.5K

Citations

12

H-Index

	Year	Citations
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis Keith D. Lindor, E. Rolland Dickson, William P. Baldus, Gastroenterology HepatologyBiliary TractMedicineLiver PhysiologyBiliary Disorder	1994	487
Endoscopic Perforation of The Colon: Lessons From A 10-Year Study Monte L. Anderson, Tousif M. Pasha, Jonathan A. Leighton The American Journal of Gastroenterology	2000	404
Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial Paul Angulo, E. Rolland Dickson, Terry M. Therneau, Journal of Hepatology HepatologyBiliary TractMedicineLiver PhysiologyBiliary Disorder	1999	132
Laparoscopic Repair of Colonoscopic Perforations: Indications and Guidelines Adam J. Hansen, Deron J. Tessier, Monte L. Anderson, Journal of Gastrointestinal Surgery LaparoscopyGastroenterologyColonoscopic PerforationsSurgeryMedicine	2007	81
Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study. Keith D. Lindor, Roberta A. Jorgensen, Monte L. Anderson, PubMed	1996	81
Accuracy of assessment of the extent of examination by experienced colonoscopists Monte L. Anderson, Russell I. Heigh, Gretchen A. McCoy, Gastrointestinal Endoscopy Colorectal SurgeryAbdominal ImagingGastroenterologyDiagnosisOutcomes Research	1992	79
Hepatic Steatosis in Hepatitis C Virus Genotype 3 Infection: Does It Correlate with Body Mass Index, Fibrosis, and HCV Risk Factors? Pratima Sharma, Vijayan Balan, Jose Luis Hernández‐Davó, Digestive Diseases and Sciences PathologyFatty Liver DiseaseCirrhosisAutoimmune Liver DiseaseObesity	2004	72
Cyclophosphamide-Induced Hepatotoxicity in a Patient With Wegener's Granulomatosis Linda Snyder, Russell I. Heigh, Monte L. Anderson Mayo Clinic Proceedings Autoimmune DiseaseHepatologyCyclophosphamide-induced HepatotoxicityLiver PhysiologyHistopathology	1993	45
Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C David D. Douglas, Jorge Rakela, Hsiang Ju Lin, Digestive Diseases and Sciences VaccinationHepatologyHepatitis CViral HepatitisImmunology	1993	41
The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: The results of a pilot study Keith D. Lindor, Rolland E. Dickson, Roberta A. Jorgensen, Hepatology HepatologyBiliary TractLiver PhysiologyPharmacologyHepatitis	1995	27

Page 1